Retatrutide (also known as LY3437943) is a novel multi-receptor agonist that activates GLP-1 (glucagon-like peptide-1) receptors, GIP (Glucose-dependent insulin stimulation) receptors, and GCG (glucagon) receptors. Helps with weight loss by promoting weight loss, improving insulin sensitivity, and controlling appetite. Compared to conventional single-receptor agonists such as GLP-1, Retatrutide's multiple mechanisms make it potentially useful …